Clinical Trial Update: ALTO-100 in MDD and/or PTSD [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for ALTO-100 in major depressive disorder and post-traumatic stress disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Post-traumatic Stress Disorder

Drugs mentioned

• ALTO-100

Snippet

Sponsor: Alto Neuroscience | Conditions: Major Depressive Disorder, Post Traumatic Stress Disorder | Phase 2 | Status: COMPLETED